Skip to content

Feasibility of the Adapted H-GRASP Feedback Program in the Chronic Phase Post Stroke.

The Feasibility of the Adapted H-GRASP Feedback Program for Perceived and Daily Life UL Activity in Patients With Good Observed But Low Perceived Activity in the Chronic Phase Post Stroke: a Pilot Study.

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05227521
Enrollment
19
Registered
2022-02-07
Start date
2022-01-31
Completion date
2023-06-25
Last updated
2023-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

upper limb, daily life activity, home-based exercise program, feedback, perceived activity

Brief summary

In a recent cross-sectional study, it was shown that people with a good observed upper limb (UL) motor function but low perceived UL activity show a reduced daily-life UL activity. The investigators will now investigate the feasibility of a phone-monitored home exercise and feedback program for the UL following stroke and the preliminary effects on the perceived UL activity and actual daily-life UL activity for participants with good observed UL motor function but low perceived UL activity in the chronic phase post-stroke.

Interventions

BEHAVIORALAdapted H-GRASP feedback program

Combination of the Home-Graded Repetitive Arm Supplementary Program with in home accelerometer-based feedback

Sponsors

Universitaire Ziekenhuizen KU Leuven
CollaboratorOTHER
KU Leuven
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Voluntary written informed consent of the participant has been obtained prior to any screening procedures 2. First-ever unilateral, supratentorial stroke, as defined by the American Heart Association/American Stroke Association 3. Minimum six months after stroke 4. Living in the community 5. ≥18 years old 6. Good observed UL motor function but low perceived UL activity. Good observed UL motor function is defined as a score \>50/66 on the Fugl-Meyer Assessment-Upper Extremity (FMA-UE). Low perceived UL activity is defined as a score ≤75/100 on the hand subscale of the Stroke Impact Scale version 3.0 (SIS-Hand).

Exclusion criteria

1. Other neurological condition than stroke 2. Musculoskeletal disorder that affects UL use 3. No informed consent 4. Participation in an interventional Study with an investigational medicinal product (IMP) or device

Design outcomes

Primary

MeasureTime frameDescription
Hand subscale of the Stroke Impact Scale version 3.0 (SIS-Hand)Day 1 (enrolment)Perceived activity of the affected UL. Minimum 0 - maximum 100; higher scores mean better outcome.
Activity ratioDay 1 (enrolment)Contribution to the activity of one upper limb (UL) versus the other: hours of activity of the affected divided by the unaffected UL
Safety45 days (post-intervention)\# of participants with increased pain while performing exercises as measured by visual analogue scale
Adherence to the intervention protocol45 days (post-intervention)% of participants who achieved 12 hours of average weekly exercise
Retention rate45 days (post-intervention)% of participants who completed the intervention
Recruitment rate45 days (post-intervention)% of individuals who were eligible and agreed to participate

Secondary

MeasureTime frameDescription
Motor Activity Log - 14 Item Version Amount Of Use (MAL-14 AOU)Day 17 (baseline), 45 days (post-intervention)Patient-reported amount of UL use in daily life
Motor Activity Log - 14 Item Version Quality Of Movement (MAL-14 QOM)Day 17 (baseline), 45 days (post-intervention)Patient-reported quality of UL use in daily life
Bilateral magnitudeDay 1 (enrolment), day 17 (baseline), 45 days (post-intervention)Intensity of the movement: sum of the vector magnitude from the two ULs
Visual Analogue Scale (VAS)Day 17 (baseline), 45 days (post-intervention)Pain intensity in the affected UL from 0 (no pain) to 10 (extreme). Minimum 0, maximum 10, higher scores mean worse outcome.
EuroQol Five Dimensions Five Levels Questionnaire (EQ-5D-5L)Day 17 (baseline), 45 days (post-intervention)Health-related quality of life. Minimum 0, maximum 100, higher scores mean better outcome.
Fugl-Meyer motor assessment - upper extremity (FMA-UE)Day 1 (enrolment), day 17 (baseline), 45 days (post-intervention)Observed motor function of the affected UL (shoulder, arm, wrist, hand, and fingers)
Action Research Arm Test (ARAT)Day 17 (baseline), 45 days (post-intervention)Grasp, grip, pinch and gross movement of the affected UL
Erasmus modified Nottingham Sensory Assessment (Em-NSA)Day 17 (baseline), 45 days (post-intervention)Sensory assessment of the UL
simplified modified Rankin Scale questionnaire (smRSq)Day 17 (baseline), 45 days (post-intervention)Global disability. Minimum 0 - maximum 5; higher scores mean worse outcome.
Hospital Anxiety and Depression Scale (HADS)Day 17 (baseline), 45 days (post-intervention)Symptoms of anxiety and depression. Minimum 0 - maximum 42; higher scores mean worse outcome.
Confidence in Arm and Hand Movement Scale (CAHM)Day 17 (baseline), 45 days (post-intervention)Perceived self-efficacy in performing tasks with the affected UL. Minimum 0 - maximum 100; higher scores mean better outcome.
Hours of UL activityDay 1 (enrolment), day 17 (baseline), 45 days (post-intervention)Sum of all seconds recorded when the activity count was nonzero and converted to hours
Magnitude ratioDay 1 (enrolment), day 17 (baseline), 45 days (post-intervention)Contribution to the activity of one limb versus the other: natural log of the vector magnitude of the affected UL divided by the vector magnitude of the unaffected UL, whereby values greater than and less than -7 were replaced by 7 and -7, respectively, to categorize single limb movement.
Density plotDay 1 (enrolment), day 17 (baseline), 45 days (post-intervention)Graphical representation of accelerometry data from both ULs

Other

MeasureTime frameDescription
DemographicsDay 1 (enrolment)Participant demography
Stroke event dataDay 1 (enrolment)Disease characteristics
Barthel Index (BI)Day 1 (enrolment)Performance in activities of daily living
Apples TestDay 1 (enrolment)Visuospatial neglect
Montreal Cognitive Assessment (MoCA)Day 1 (enrolment)Cognitive function
Edinburgh Handedness Inventory (EHI)Day 1 (enrolment)Handedness
National Institutes of Health Stroke Scale (NIHSS)Day 1 (enrolment)Neurological impairments. Minimum 0, maximum 42, higher scores mean worse outcome.

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026